Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,881
Closed -$953K 1620
2022
Q3
$953K Buy
3,881
+2,342
+152% +$632K 0.24% 61
2022
Q2
$381K Buy
1,539
+137
+10% +$37K 0.16% 192
2022
Q1
$464K Buy
+1,402
New +$432K 0.2% 154
2021
Q3
Sell
-2,784
Closed -$869K 1181
2021
Q2
$869K Buy
+2,784
New +$854K 0.29% 60

Other funds holding ABMD

XTX Topco's ABMD Position: Q4 2022 in Review

XTX Topco sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,881 shares — an estimated $953K sold.

XTX Topco first reported a position in ABMD in Q2 2021 and held it in 4 quarters. The position peaked at $953K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • XTX Topco reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • XTX Topco sold 3,881 Abiomed Inc shares in Q4 2022, an estimated $953K.
  • XTX Topco first reported a position in Abiomed Inc in Q2 2021 and held it in 4 quarters.
  • XTX Topco's Abiomed Inc position peaked at $953K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on XTX Topco's 13F filing for Q4 2022, filed 14 Feb 2023.